After Approval: Launch Timeline Why There's Always a Gap Between Approval and Availability Manufacturing Scale-Up: Clinical trials require thousands of doses per month
With the FDA approval of Wegovy HD (7.2 mg) in March 2026, a higher dose option is now available
Data from both HPLC-UV and MS are analyzed to identify the peptide, assess purity, and detect any modifications, providing comprehensive characterization essential for pharmaceutical quality control and research purposes
Introducing Retatrutide at Renaissance MD in Redlands May 31 3 min read The Next Evolution in Medical Weight Management Has Arrived At Renaissance MD, we are committed to bringing our patients the latest innovations in wellness and weight management
Think of GLP-1 therapy as a bridge
When metabolism improves, the body's natural hormone systemsincluding GLP-1often function more effectively